Drug Trial Radar · NCT06442462
Study of SPG302 in Adults With Schizophrenia
Last checked: Nov 19, 2026Latest source record: Feb 6, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Active, not recruiting
Enrollment
32
Planned (sponsor's estimate)
Start
Aug 1, 2024
Primary completion
Mar 2026
Study completion Mar 2026
Sponsor
- Lead sponsor
- SpinogenixIndustry
- Sponsor type
- Industry
- First posted
- Jun 4, 2024
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 65 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This Phase 2 study described herein will evaluate the safety, efficacy, tolerability, and pharmacodynamics of SPG302 in adults with a primary diagnosis of schizophrenia.
Conditions
- Schizophrenia
Interventions
SPG302Drug
small synthetic molecule
PlaceboDrug
Placebo
Primary outcomes
What the sponsor says the trial is designed to measure.
- Positive and Negative Symptoms Scale (PANSS Score) as determined by clinicianTime frame: 6 weeks
- Electroencephalogram analysis to assess brain electrical activityTime frame: 6 weeks
- Change in smooth pursuit eye tracking from baselineTime frame: 6 weeks
Locations
3 sites in 2 countries. Site status is shown where the registry gives one.
CenExel CNS
Garden Grove, California
Box Hill Hospital - Eastern Health
Box Hill, Victoria, Australia
Multidisciplinary Alfred Psychiatry Research Centre (MAPrc)
Melbourne, Victoria, Australia
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.